Gene Signatures of Influenza Vaccine Responses in Older Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

August 27, 2018

Primary Completion Date

January 2, 2019

Study Completion Date

January 2, 2019

Conditions
Influenza
Interventions
DRUG

Fluad Vaccine

FLUAD is an inactivated influenza vaccine indicated for active immunization against influenza. disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUAD is. approved for use in persons 65 years of age and older.

DRUG

Fluzone High-Dose

FLUZONE® HIGH-DOSE vaccine is indicated for people 65 years of age and older to help prevent influenza disease caused by influenza A and B strains contained in the vaccine.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Mayo Clinic

OTHER

NCT03603509 - Gene Signatures of Influenza Vaccine Responses in Older Adults | Biotech Hunter | Biotech Hunter